Low-dose Naltrexone for Bladder Pain Syndrome

NCT04450316 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

40

Enrollment

OTHER

Sponsor class

Stopped Study temporarily suspended awaiting research personnel to resume recruitment

Conditions

Bladder Pain Syndrome
Interstitial Cystitis

Interventions

DRUG: Naltrexone
DRUG: Placebo

Sponsor

Stanford University